20 Amendments of Margrete AUKEN related to 2011/2193(INI)
Amendment 5 #
Motion for a resolution
Citation 11 a (new)
Citation 11 a (new)
- having regard to the European Parliaments Resolution on the trade in human egg cells from March 10th 2005
Amendment 16 #
Motion for a resolution
Recital M a (new)
Recital M a (new)
Ma. Whereas the donation of some tissues and cells creates a severe risk for the donor, whereas this risk is particular high in egg-cell donation because of the hormone treatment which is necessary to prepare the donation;
Amendment 17 #
Motion for a resolution
Recital M b (new)
Recital M b (new)
Mb. Whereas the Charta of Fundamental Rights which is the leading principle for the European Union and legally binding after entering into force of the Lisbon Treaty prohibits making the human body and its parts as such a source of financial gain.
Amendment 18 #
Motion for a resolution
Recital M c (new)
Recital M c (new)
Mc. Whereas unpaid donation is not only an ethical principle but also necessary to protect the health of the donor and the recipient as the involvement of high amounts of money in the donation process may stimulate the donor to take risks and may hinder the disclosure of risks in his/her medical history.
Amendment 20 #
Motion for a resolution
Recital M e (new)
Recital M e (new)
Me. Whereas serious media again and again report that in the area of tissues and cells the principle of unpaid donation is violated.
Amendment 22 #
Motion for a resolution
Recital M g (new)
Recital M g (new)
Mg. Whereas there is a significant amount of evidence that allogenic cordbloood transplantation is successful for many patients; on the other hand, there is only very limited evidence about the potential success of autologous treatment with cordblood;
Amendment 23 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Welcomes the Seconclusd Report on Voluntary and Unpaid Donations of the Second Report on VTissues and Cells which indicated that a significant amount of measures have been taken by Member States to ensure voluntary and Uunpaid Ddonation of Tissues and Cells, however, the report also showed that implementation is not yet complete; calls on Member States to fully implement the Directive and on the Commission to take all necessary measures to ensure this;
Amendment 31 #
Motion for a resolution
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Asks the Commission to carefully monitor the development in the Member States and to examine carefully any reports by actors in the civil society and media under violation of the principle and draw appropriate consequences if necessary infringement procedures.
Amendment 35 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Calls on Member States to clearly define the conditions under which financial compensation may be granted, bearing in mind that compensation is strictly limited to conditions making good the actual expenses incurred in donating an organtissues and cells, such as travel expenses, loss of earnings or medical costs, thereby prohibiting any financial incentives orand avoiding disadvantages for a potential donor;
Amendment 43 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Underlines nonethelesConsiders that the principle of altruism ris not necessarilyks to be violated through the use of non- financial incentives such as benefits-in- kind, which can make donation less burdensome and more attractive, whilst ensuring that the human body shall not be a sourcebe seen as another form of financial gain;
Amendment 52 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Highlights the legal and ethical problems posed by the existence ofat websites permitting people to sell or purchase gametes online; calls on Member States to consider regulating this area to prevent the possible emergence of an online black market clearly violate the principle of unpaid donation; calls on Member States to prohibit such practices, and calls on the Commission to take regulatory action should national action not suffice as such practices risk to undermine the quality and safety of tissues and cells;
Amendment 65 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Underlines the importance of encouraging mothers to donatinge cord blood and tissue at birth either into public or privatet birth to public banks to help treat illnesses and further research in the field;
Amendment 75 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Calls on Member States to raise awareness of public and private cord blood banking through information campaigns that may take place, for example, during antenatal classes;
Amendment 79 #
Motion for a resolution
Paragraph 16 c (new)
Paragraph 16 c (new)
16c. Considers that public authorities should not promote donations of cord blood to private banks, given that the benefits of autologous treatment are yet to be proven;
Amendment 80 #
Motion for a resolution
Paragraph 16 d (new)
Paragraph 16 d (new)
16d. Has serious doubts that private cord blood banks for potential autologous treatment comply with the Charta of Fundamental Rights, which prohibits making the human body and its parts as such a source of financial gain;
Amendment 81 #
Motion for a resolution
Paragraph 17
Paragraph 17
17. Proposes that Member States consider adopting and enforcing common operational and ethical standards for both public and private cord blood banks, such as that ensure inter alia respect for those proposed by non-profit organisations such as the International Netcord Foundation and the Foundation for the Accreditation of Cellular Therapy (FACT)inciple of non- commercialisation of the human body and its parts and that ensure traceability;
Amendment 93 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. Encourages public and private cord blood banks to collaborate more closely in order to increase the availability of national cord blood and tissue samples;
Amendment 97 #
Motion for a resolution
Paragraph 22
Paragraph 22
22. Stresses that in order to guarantee respect for the existing regulatory diversity across Member States whichUnderlines that it is Member States competence to allow, prohibit or regulate research with human embryonic stem cells and in vitro fertilisation but that Member States in this respect need to reflspects differing national values and practices in this field, the s the rules set out in the Directive 2004/23 including the quality and safety and the principal of unpaid donation. Points out that the European Union has limited compe oftence in this areport does not include issues surrounding embryonic stem cell research, therapeutic cloning and in-vitro fertilisation;a and needs to respect when applying this competence the principles of the charter of fundamental rights and the principles applied in the judgement of the European Court of Justice.
Amendment 98 #
Motion for a resolution
Paragraph 23
Paragraph 23
23. Calls on the Commission to consider revising the principles governing tissue and cell donation as laid down inpropose as soon as possible a revision of the Directive 2004/23/EC, in order to bring them into line with the principles governing organ donation laid down in Directive 2010/45/EU, and to take into account of scientific developments and the the new legal situation after the entering into force of the Lisbon Treaty and to take into account the scientific developments, the practical experience of actors in the sector and the recommendations of this report;
Amendment 99 #
Motion for a resolution
Paragraph 23 a (new)
Paragraph 23 a (new)
23a. Asks the Commission to also propose a revision of Regulation EC 1394/2007 in order to include provision that guarantees the application of the principle of unpaid donation similar to the Directive 2010/45 and to take into account the problems in the implementation of the regulation especially for SMEs.